Efficacy and safety of donafenib plus transarterial chemoembolization and immunotherapy for hepatocellular carcinoma
TACE combined with donafenib and ICI is a promising and safe therapeutic regimen for unresectable HCC.
Authors
- Franklin Chu
- Zhihao Yang (ORCID: https://orcid.org/0000-0002-6134-5737)
- Sinan Liu (ORCID: https://orcid.org/0000-0002-5180-4370)
- Xiang Chen (ORCID: https://orcid.org/0000-0003-1561-0058)
- Cheng Yang (ORCID: https://orcid.org/0009-0009-3688-8180)
Institutions
- Second Military Medical University (CN)
- Nantong University (CN)
- Affiliated Hospital of Nantong University (CN)
- Second People's Hospital of NanTong (CN)
- Eastern Hepatobiliary Surgery Hospital (CN)
Publication Details
- Journal
- World Journal of Gastrointestinal Oncology
- Published
- 2025-06-13
- DOI
- https://doi.org/10.4251/wjgo.v17.i6.105170
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00